Stay updated with breaking news from 11012210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apollon Wealth Management LLC raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 77,741 shares of the biopharmaceutical company’s stock after purchasing an additional 3,525 shares during the period. Apollon Wealth Management LLC’s holdings in Bristol-Myers […] ....
Maryland State Retirement & Pension System lessened its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 158,516 shares of the biopharmaceutical company’s stock after selling 3,406 shares during the period. Maryland State Retirement & Pension System’s holdings in Bristol-Myers Squibb were worth […] ....
Apollon Wealth Management LLC boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 77,741 shares of the biopharmaceutical company’s stock after buying an additional 3,525 shares during the quarter. Apollon Wealth Management LLC’s holdings in Bristol-Myers Squibb were worth $3,989,000 […] ....
Machina Capital S.A.S. boosted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 8.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,912 shares of the biopharmaceutical company’s stock after buying an additional 885 shares during the quarter. Machina Capital […] ....
Clifford Swan Investment Counsel LLC lowered its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 423,824 shares of the biopharmaceutical company’s stock after selling 14,923 shares during the quarter. Clifford Swan Investment Counsel LLC’s holdings in Bristol-Myers Squibb were worth $21,746,000 at […] ....